Skip to main content

1-12 of 12 results for subject:Arthritis

Session X
2006-07

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

There are persistent rumours in this place about an early prorogation, so there must be plenty of vacant slots into which debates can be inserted. Will the Leader of the House arrange a debate on a topic of concern to 15,000 people in my constituency, and, indeed, people in every...

Member
David Leslie Taylor (Labour; Co-operative Party)
Type
Business questions
Date
11 October 2007
Reference
464 c460
House
House of Commons

My hon. Friend makes an important point, which I shall draw to the attention of my colleagues in the Department of Health. It may well be right to issue a written ministerial statement on national arthritis day.

Member
Baroness Harman (Labour)
Type
Proceeding contributions
Date
11 October 2007
Reference
464 c460
House
House of Commons

To ask the Secretary of State for Health what treatment options are available to people with juvenile arthritis.

Asked by
Greg Hands (Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
26 July 2007
Reference
153343; 463 c1275W
House
House of Commons

To ask the Chancellor of the Exchequer (1) how many children under the age of 16 years in (a) the Jarrow constituency, (b) South Tyneside, (c) the North East and (d) the UK died from the juvenile form of rheumatoid arthritis in each year since 1997;

Asked by
Stephen Hepburn (Labour)
Answering body
Treasury
Type
Written questions
Status
Answered
Date
11 June 2007
Reference
140826; 461 c821-2W;461 c820-2W
House
House of Commons

To ask the Secretary of State for Health whether the cost effectiveness models used by the National Institute for Health and Clinical Excellence take into account potential savings in work-related benefits of treatments which enable people with rheumatoid arthritis to remain in or return to work.

Asked by
Janet Dean (Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
4 June 2007
Reference
136380; 461 c278W
House
House of Commons

To ask the Secretary of State for Health (1) what the evidential basis is for the statement made in the Musculoskeletal Service Framework that the year-on-year costs of TNF alpha inhibitors are likely to be offset by keeping patients with rheumatoid arthritis (RA) at work and reducing the need for...

Asked by
Janet Dean (Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
15 May 2007
Reference
136377; 460 c715-6W
House
House of Commons

(2) what steps she has taken to ensure that the clinical assessment treatment services envisaged by the Musculoskeletal Service Framework include expertise in rheumatology to enable patients with rheumatoid arthritis to be diagnosed at the earliest opportunity.

Asked by
Janet Dean (Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
15 May 2007
Reference
136379; 460 c715-6W
House
House of Commons

asked Her Majesty's Government:Whether their policy on cannabis reflects the possibility that cannabis is capable of relieving severe pain suffered by victims of arthritis.

Asked by
Lord Lester of Herne Hill (Liberal Democrat)
Type
Written questions
Status
Answered
Date
26 March 2007
Reference
2624; 690 c234WA
House
House of Lords

To ask the Secretary of State for Health whether she plans to issue guidelines on (a) the monitoring of patient outcomes for patients referred to clinical assessment teams, particularly for patients with serious inflammatory diseases such as rheumatoid arthritis and (b) the training of staff being recruited to clinical assessment...

Asked by
David Amess (Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
8 March 2007
Reference
457 c2204W;457 c2190W; 119492
House
House of Commons

I refer to an Iranian movement which is concerned about the President of Iran and everything that goes on in that country. It seeks justice for the people in Iran. There was a hearing at the European Court of Justice on 12 December, which annulled the court’s decision to include...

Member
David Amess (Conservative)
Type
Proceeding contributions
Date
19 December 2006
Reference
454 c1343-4
House
House of Commons

Before the House adjourns for the Christmas recess there are a number of points that I want to raise that relate to the subjects of democracy and justice. We live in extraordinary political times. Earlier this week we saw the Prime Minister visiting our troops in Iraq. The troops were...

Member
David Amess (Conservative)
Type
Proceeding contributions
Date
19 December 2006
Reference
454 c1341-3
House
House of Commons

To ask the Secretary of State for Health what assessment she has made of the extent to which NHS patients have access to the new generation of anti-TNF drugs for rheumatoid arthritis.

Asked by
Mike Hancock (Liberal Democrat)
Answering body
Department of Health
Type
Written questions
Status
Answered
Date
30 November 2006
Reference
103058; 453 c921W
House
House of Commons